P1101: PIRTOBRUTINIB, A HIGHLY SELECTIVE, NON-COVALENT (REVERSIBLE) BTK INHIBITOR IN PREVIOUSLY TREATED MANTLE CELL LYMPHOMA: UPDATED RESULTS FROM THE PHASE 1/2 BRUIN STUDY
HemaSphere | June 23, 2022 | Volume: 6 | Issue: No issue available | Pages: 991-992
10.1097/01.hs9.0000847272.47630.ff